Literature DB >> 17591082

Genetic analysis of hepatitis A virus protein 2C in sera from patients with fulminant and self-limited hepatitis A.

Keiichi Fujiwara1, Osamu Yokosuka, Fumio Imazeki, Makoto Miki, Kazuyuki Suzuki, Kiwamu Okita, Eiji Tanaka, Masao Omat.   

Abstract

BACKGROUND/AIMS: To examine whether genetic differences in hepatitis A virus (HAV) are responsible for the range of clinical severities, we analyzed the HAV 2C genome, whose mutations have previously been shown to be important for enhanced replication in cell culture systems and to be related to virulence in simians.
METHODOLOGY: Serum samples from 45 Japanese patients with sporadic hepatitis A, comprising 9 patients with fulminant hepatitis (FH), 10 with severe acute hepatitis (AHs), and 26 with self-limited acute hepatitis (AH), were examined for HAV RNA.
RESULTS: Compared with the sequence of wild-type HAV strain HM-175, the nucleotide sequences of 2C had homology of 89.0 +/- 0.6% in FH, 88.6 +/- 0.9% in AHs, and 89.0 +/- 1.6% in AH. Differences were not statistically significant among the three groups. Deduced amino acid sequences had homology of 97.6 +/- 0.4% in FH, 96.5 +/- 1.9% in AHs, and 96.8 +/- 1.7% in AH. The difference between FH and AH was statistically significant (p < 0.05), although there were no specific nucleotide or amino acid substitutions.
CONCLUSIONS: Fulminant hepatitis patients had fewer amino acid substitutions in 2C, indicating the association between severity of hepatitis A and amino acid variations in 2C of HAV.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17591082

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  2 in total

1.  Analysis of hepatitis A virus protein 2B in sera of hepatitis A of various severities.

Authors:  Keiichi Fujiwara; Osamu Yokosuka; Fumio Imazeki; Makoto Miki; Kazuyuki Suzuki; Kiwamu Okita; Eiji Tanaka; Masao Omata
Journal:  J Gastroenterol       Date:  2007-07-25       Impact factor: 7.527

Review 2.  Pathogenicity and virulence of hepatitis A virus.

Authors:  Rosa M Pintó; Francisco-Javier Pérez-Rodríguez; Maria-Isabel Costafreda; Gemma Chavarria-Miró; Susana Guix; Enric Ribes; Albert Bosch
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.